NewGLab Pharma Co Ltd
KOSDAQ:214870
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
NewGLab Pharma Co Ltd
Accrued Liabilities
NewGLab Pharma Co Ltd
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
NewGLab Pharma Co Ltd
KOSDAQ:214870
|
Accrued Liabilities
₩3.1B
|
CAGR 3-Years
138%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
|
V
|
Vidente Co Ltd
KOSDAQ:121800
|
Accrued Liabilities
₩4.9B
|
CAGR 3-Years
161%
|
CAGR 5-Years
121%
|
CAGR 10-Years
30%
|
|
|
T
|
Tovis Co Ltd
KOSDAQ:051360
|
Accrued Liabilities
₩3.2B
|
CAGR 3-Years
47%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-6%
|
|
|
F
|
Furonteer Co Ltd
KOSDAQ:370090
|
Accrued Liabilities
₩1.9B
|
CAGR 3-Years
156%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Park Systems Corp
KOSDAQ:140860
|
Accrued Liabilities
₩3.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
W
|
Woori Technology Inc
KOSDAQ:032820
|
Accrued Liabilities
₩1.5B
|
CAGR 3-Years
29%
|
CAGR 5-Years
18%
|
CAGR 10-Years
21%
|
|
NewGLab Pharma Co Ltd
Glance View
NewGLAB Pharma Co., Ltd. engages in the manufacture of closed-circuit television camera and equipment. The company is headquartered in Bucheon, Gyeonggi-Do. The company went IPO on 2015-10-13. The firm's product portfolio consists of general analog cameras that used for CCTVs, high definition (HD) analog cameras, HD-serial digital interface (SDI) cameras, extend (EX)-SDI cameras, internet protocol (IP) cameras that used for network CCTVs, digital video recorders (DVRs) that used for image storage devices, network video recorders (NVRs) and others. In addition, the Company is involved in the business of 5G smartphone distribution. The firm distributes its products within domestic market and to overseas markets.
See Also
What is NewGLab Pharma Co Ltd's Accrued Liabilities?
Accrued Liabilities
3.1B
KRW
Based on the financial report for Sep 30, 2024, NewGLab Pharma Co Ltd's Accrued Liabilities amounts to 3.1B KRW.
What is NewGLab Pharma Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
57%
Over the last year, the Accrued Liabilities growth was 46%. The average annual Accrued Liabilities growth rates for NewGLab Pharma Co Ltd have been 138% over the past three years , 57% over the past five years .
You don't have any saved screeners yet
